|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
LIVER AND BILIARY TRACT
1Department of Pediatrics, and 2Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas; and 3University of Colorado Health Sciences Center, Denver, Colorado
Submitted 17 June 2008 ; accepted in final form 1 September 2008
Extracellular ATP regulates bile formation by binding to P2 receptors on cholangiocytes and stimulating transepithelial Cl– secretion. However, the specific signaling pathways linking receptor binding to Cl– channel activation are not known. Consequently, the aim of these studies in human Mz-Cha-1 biliary cells and normal rat cholangiocyte monolayers was to assess the intracellular pathways responsible for ATP-stimulated increases in intracellular Ca2+ concentration ([Ca2+]i) and membrane Cl– permeability. Exposure of cells to ATP resulted in a rapid increase in [Ca2+]i and activation of membrane Cl– currents; both responses were abolished by prior depletion of intracellular Ca2+. ATP-stimulated Cl– currents demonstrated mild outward rectification, reversal at ECl–, and a single-channel conductance of
17 pS, where E is the equilibrium potential. The conductance response to ATP was inhibited by the Cl– channel inhibitors NPPB and DIDS but not the CFTR inhibitor CFTRinh-172. Both ATP-stimulated increases in [Ca2+]i and Cl– channel activity were inhibited by the P2Y receptor antagonist suramin. The PLC inhibitor U73122
[GenBank]
and the inositol 1,4,5-triphosphate (IP3) receptor inhibitor 2-APB both blocked the ATP-stimulated increase in [Ca2+]i and membrane Cl– currents. Intracellular dialysis with purified IP3 activated Cl– currents with identical properties to those activated by ATP. Exposure of normal rat cholangiocyte monolayers to ATP increased short-circuit currents (Isc), reflecting transepithelial secretion. The Isc was unaffected by CFTRinh-172 but was significantly inhibited by U73122
[GenBank]
or 2-APB. In summary, these findings indicate that the apical P2Y-IP3 receptor signaling complex is a dominant pathway mediating biliary epithelial Cl– transport and, therefore, may represent a potential target for increasing secretion in the treatment of cholestatic liver disease.
cholangiocyte; ATP; purinergic signaling; P2Y receptor; Cl– channel; inositol 1,4,5-triphosphate
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |